DrugPatentWatch Database Preview
TESTOSTERONE Drug Profile
see a sample report or, see our see our flat-rate plans
When do Testosterone patents expire, and when can generic versions of Testosterone launch?
Testosterone is a drug marketed by Actavis Labs Ut Inc, Perrigo Israel, Ani Pharms Inc, Par Pharm, Perrigo Uk Finco, Watson Labs, Cipla Ltd, Lupin Ltd, Hikma Farmaceutica, Luitpold, Mylan Institutional, Paddock Llc, Sandoz Inc, Sun Pharm Inds Ltd, Watson Pharms Inc, West-ward Pharms Int, Nexus Pharms, Bel Mar, Elkins Sinn, and Lilly. and is included in forty-three NDAs.
The generic ingredient in TESTOSTERONE is testosterone propionate. There are sixty-five drug master file entries for this compound. There is one tentative approval for this compound. Additional details are available on the testosterone propionate profile page.
Summary for TESTOSTERONE
Pharmacology for TESTOSTERONE
| Ingredient-type | Androstanes |
| Drug Class | Androgen |
| Mechanism of Action | Androgen Receptor Agonists |
Synonyms for TESTOSTERONE
| (+-)-8-iso-testosterone |
| (+-)-retrotestosterone |
| (+-)-testosterone |
| (+)-testosterone |
| (17?)-17-Hydroxyandrost-4-en-3-one |
| (17b)-17-hydroxy-androst-4-en-3-one |
| (17beta)-17-Hydroxyandrost-4-en-3-one |
| (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one |
| (1S,2R,10R,11S,14S,15S)-14-HYDROXY-2,15-DIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-5-ONE |
| (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one |
| (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one |
| (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| (8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one |
| 003T654 |
| 1050678-68-6 |
| 13-iso-testosterone |
| 17-.beta.-Hydroxyandrost-4-en-3-one |
| 17-beta-Hydroxy-delta(sup 4)-androsten-3-one |
| 17-beta-Hydroxyandrost-4-en-3-one |
| 17-Hydroxy-(17-beta)-androst-4-en-3-one |
| 17-Hydroxy-(17beta)-androst-4-en-3-one |
| 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one |
| 17-Hydroxy-4-androsten-3-one |
| 17-hydroxy-androst-4-en-3-one |
| 17-hydroxy-D4-androsten-3-one |
| 17-Hydroxyandrost-4-en-3-one, (17.beta.)- |
| 17.beta.-Hydroxy-.DELTA.4-androsten-3-one |
| 17.beta.-Testosterone |
| 17a-hydroxy-(13a)-androst-4-en-3-one |
| 17a-hydroxy-13a-androst-4-en-3-one |
| 17a-hydroxy-14b-androst-4-en-3-one |
| 17a-hydroxy-androst-4-en-3-one |
| 17b-hydroxy-(10a)-androst-4-en-3-one |
| 17b-hydroxy-(13a)-androst-4-en-3-one |
| 17b-hydroxy-(8a,10a)-androst-4-en-3-one |
| 17b-hydroxy-(8a)-androst-4-en-3-one |
| 17b-hydroxy-(9b,10a)-androst-4-en-3-one |
| 17b-hydroxy-(9b)-androst-4-en-3-one |
| 17b-hydroxy-13a-androst-4-en-3-one |
| 17b-hydroxy-4-androsten-3-one |
| 17b-hydroxy-8a-androst-4-en-3-one |
| 17b-Hydroxy-androst-4-en-3-on |
| 17b-hydroxy-androst-4-en-3-one |
| 17b-Hydroxy-D4-androsten-3-one |
| 17b-Hydroxyandrost-4-ene-3-one |
| 17b-Testosterone |
| 17beta-Hydroxy-3-oxo-4-androstene |
| 17beta-Hydroxy-4-androsten-3-one |
| 17beta-hydroxy-4-androsten-3one |
| 17beta-Hydroxy-delta(sup4)-androsten-3-one |
| 17beta-Hydroxyandrost-4-en-3-one |
| 17beta-Hydroxyandrost-4-ene-3-one |
| 17beta-testosterone |
| 1i37 |
| 3kdm |
| 3XMK78S47O |
| 4-androsten-17-ol-3-one |
| 4-Androsten-17.beta.-ol-3-one |
| 4-Androsten-17beta-ol-3-one |
| 4-Androsten-3-one-17.beta.-ol |
| 4-Androsten-3-one-17b-ol |
| 4-Androsten-3-one, 17b-hydroxy- |
| 4-androstene-17beta-ol-3-one |
| 58-22-0 |
| 7-beta-Hydroxyandrost-4-en-3-one |
| 8-iso-testosterone |
| 9b-testosterone |
| 9b,10a-testosterone |
| AA 2500 |
| AB00973630-03 |
| AC-14899 |
| AC1L1LM0 |
| AK405367 |
| AKOS015894897 |
| AN-23597 |
| Andro 100 |
| Androderm |
| Androderm (TN) |
| Androderm, Delatestryl |
| AndroGel |
| Androgel (TN) |
| Androgel 1.62% |
| Androgel 1% |
| Androlin |
| Andronaq |
| Andronate 100 |
| Andronate 200 |
| Andropatch |
| Andropository 200 |
| Androsorb |
| Androst-4-en-17b-ol-3-one |
| Androst-4-en-17beta-ol-3-one |
| Androst-4-en-3-on-17B-ol |
| Androst-4-en-3-one, 17-beta-hydroxy- |
| Androst-4-en-3-one, 17-hydroxy-, (17-beta)- |
| Androst-4-en-3-one, 17-hydroxy-, (17.beta.)- |
| Androst-4-en-3-one, 17-hydroxy-, (17b)- |
| Androst-4-en-3-one, 17-hydroxy-, (17beta)- |
| Androst-4-en-3-one, 17-hydroxy, (17.beta.)- |
| Androst-4-en-3-one, 17beta-hydroxy- |
| Androst-4-ene-17b-ol-3-one |
| Andrusol |
| Andryl 200 |
| Axiron |
| Axiron (TN) |
| B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E |
| BC208298 |
| BDBM8885 |
| beta testosterone |
| BIDD:ER0555 |
| BIM-0061761.0001 |
| Bio-0678 |
| Bio-T-Gel |
| BT000432 |
| C-18145 |
| C00535 |
| CAS-58-22-0 |
| CCG-101189 |
| CCRIS 574 |
| CDB 111C |
| CHEBI:17347 |
| CHEMBL386630 |
| CMC_13449 |
| COL 1621 |
| CompleoTRT |
| component of Di-Genik (Salt/Mix) |
| component of Di-Met (Salt/Mix) |
| component of Duogen (Salt/Mix) |
| component of Intrinsa (Salt/Mix) |
| component of Mal-O-Fem (Salt/Mix) |
| component of Tostrex (Salt/Mix) |
| CP 601B |
| CPD000058344 |
| Cristerona T |
| Cristerone T |
| CS-1415 |
| D00075 |
| D06XMU |
| D4-Androsten-17b-ol-3-one |
| DB00624 |
| delta(sup 4)-Androsten-17(beta)-ol-3-one |
| delta4-androsten-17b-ol-3-one |
| delta4-Androsten-17beta-ol-3-one |
| DSSTox_CID_2371 |
| DSSTox_GSID_22371 |
| DSSTox_RID_76563 |
| DTXSID8022371 |
| EINECS 200-370-5 |
| Epitestosteron |
| Epitope ID:135865 |
| Everone 200 |
| Fortesta |
| Geno-cristaux gremy |
| GTPL2858 |
| Halotensin |
| HMS2052N11 |
| HMS2272B03 |
| HMS2272P03 |
| Homosteron |
| Homosterone |
| HSDB 3398 |
| HY-15554A |
| Intrinsa |
| LibiGel |
| LMST02020002 |
| LS-148813 |
| Lumitestosteron |
| Malerone |
| Malestrone (amps) |
| Malogen in Oil |
| Malogen, aquaspension injection |
| MCULE-1294118086 |
| Mertestate |
| MLS000563091 |
| MLS001032098 |
| MLS001306401 |
| MLS001424262 |
| MLS002174283 |
| mpp10 |
| MUMGGOZAMZWBJJ-DYKIIFRCSA-N |
| Nasobol |
| NC00439 |
| NCGC00091018-01 |
| NCGC00258243-01 |
| Neo-Hombreol F |
| Neo-testis |
| Neotestis |
| NSC 9700 |
| Oreton |
| Oreton F |
| Oreton-F |
| Orquisteron |
| Perandren |
| Percutacrine androgenique |
| PL000185 |
| Primotest |
| Primoteston |
| Q-101251 |
| rac-17b-hydroxy-(13a)androst-4-en-3-one |
| rac-17b-hydroxy-(8a)-androst-4-en-3-one |
| rac-17b-hydroxy-(9b,10a)androst-4-en-3-one |
| rac-17b-hydroxy-androst-4-en-3-one |
| RB3046 |
| Relibra |
| RP29985 |
| S00309 |
| SC-15109 |
| Scheinpharm Testone-Cyp |
| SCHEMBL8452 |
| SMR000058344 |
| SMR001261453 |
| Striant |
| Striant (TN) |
| Sustanon |
| Sustanone |
| Sustason 250 |
| Synandrol F |
| T-Cypionate |
| Teslen |
| Testamone 100 |
| Testandrone |
| Testaqua |
| Testiculosterone |
| Testim |
| Testim (TN) |
| Testobase |
| Testoderm |
| Testoderm Tts |
| Testogel |
| Testoject-50 |
| Testolin |
| Testopel Pellets |
| Testopropon |
| Testosteroid |
| Testosteron |
| Testosterona |
| Testosterona [INN-Spanish] |
| Testosterone (JAN/USP) |
| Testosterone [Androgenic steroids, anabolic] |
| Testosterone [INN:BAN] |
| Testosterone [USP:INN:BAN] |
| Testosterone 1.0 mg/ml in Acetonitrile |
| Testosterone 100 microg/mL in Acetonitrile |
| Testosterone and its esters |
| Testosterone for impurity D identification, European Pharmacopoeia (EP) Reference Standard |
| Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Testosterone hydrate |
| Testosterone solution |
| Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard |
| Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material |
| Testosterone, >=98% |
| Testosterone, 1 |
| Testosterone, cell culture tested |
| Testosterone, European Pharmacopoeia (EP) Reference Standard |
| Testosterone, purum, >=99.0% (HPLC) |
| Testosterone, VETRANAL(TM), analytical standard |
| Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one |
| Testosteronum |
| Testosteronum [INN-Latin] |
| Testostosterone |
| Testoviron |
| Testoviron Schering |
| Testoviron T |
| Testred Cypionate 200 |
| Testrin-P.A |
| Testro AQ |
| Testrone |
| Testryl |
| Tostrelle |
| Tostrex |
| Tox21_200689 |
| trans-Testosterone |
| UNII-3XMK78S47O |
| Viatrel |
| Virilon IM |
| Virormone |
| Virosterone |
| W-5033 |
| ZINC118912393 |
US Patents and Regulatory Information for TESTOSTERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | TESTOSTERONE ENANTHATE | testosterone enanthate | INJECTABLE;INJECTION | 040647-001 | Oct 5, 2009 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sun Pharm Inds Ltd | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 201720-002 | Jun 3, 2013 | AO | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Bel Mar | TESTOSTERONE PROPIONATE | testosterone propionate | INJECTABLE;INJECTION | 080741-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
